Intravenous administration of Gd-DTPA prior to DWI does not affect the apparent diffusion constant

Gang Chen1, Sune Nørhøj Jespersen, Michael Pedersen

  • 1MR Research Center, Aarhus University Hospital, Aarhus, DK8200 Aarhus N, Denmark. gangchen@mr.au.dk

Insights

Gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA) contrast agents do not significantly alter tumor apparent diffusion constant (ADC) measurements in mice. This finding supports simultaneous MRI diffusion and perfusion imaging for evaluating tissue viability.

Area of Science:

  • Biomedical Imaging
  • Magnetic Resonance Imaging (MRI)
  • Cancer Research

Background:

  • MRI assesses organ functionality and tissue viability using water diffusion and blood perfusion measurements.
  • Diffusion-weighted imaging requires no contrast agents, while perfusion imaging typically uses agents like gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA).
  • Simultaneous diffusion and perfusion MRI are desirable, but concerns exist regarding contrast agent effects on diffusion measurements.

Purpose of the Study:

  • To investigate potential changes in apparent diffusion constant (ADC) in tumors after intravenous administration of Gd-DTPA.
  • To determine if Gd-DTPA impacts subsequent diffusion measurements in a tumor model.

Main Methods:

  • C3H mouse mammary carcinomas were used for the study.
  • Mice received intravenous injections of 0.2 and 0.4 mmol/kg Gd-DTPA.
  • ADC measurements were performed using a 7-T animal MRI system.
  • Results were compared to a control sham group.

Main Results:

  • Intravenous administration of Gd-DTPA did not cause significant changes in tumor ADC values.
  • No significant impact on ADC was observed at either 0.2 or 0.4 mmol/kg Gd-DTPA doses.
  • Comparison with the sham group confirmed the lack of Gd-DTPA interference with ADC measurements.

Conclusions:

  • Gd-DTPA does not significantly affect ADC measurements in C3H mouse mammary carcinomas.
  • Simultaneous MRI of diffusion and perfusion is feasible without concerns of contrast agent-induced alterations in ADC.
  • This supports the use of combined MRI techniques for robust tumor evaluation.

Related Concept Videos